- Home
- CPSH vs KZIA Comparison
CPSH vs KZIA Comparison
Compare CPSH & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPSH
- KZIA
- Stock Information
- Founded
- CPSH 1984
- KZIA 1994
- Country
- CPSH United States
- KZIA Australia
- Employees
- CPSH N/A
- KZIA N/A
- Industry
- CPSH Building Materials
- KZIA Biotechnology: Pharmaceutical Preparations
- Sector
- CPSH Consumer Discretionary
- KZIA Health Care
- Exchange
- CPSH Nasdaq
- KZIA Nasdaq
- Market Cap
- CPSH 23.2M
- KZIA 18.7M
- IPO Year
- CPSH 1987
- KZIA 1999
- Fundamental
- Price
- CPSH $1.58
- KZIA $3.18
- Analyst Decision
- CPSH
- KZIA Strong Buy
- Analyst Count
- CPSH 0
- KZIA 1
- Target Price
- CPSH N/A
- KZIA $20.00
- AVG Volume (30 Days)
- CPSH 38.0K
- KZIA 77.0K
- Earning Date
- CPSH 10-30-2024
- KZIA 12-27-2024
- Dividend Yield
- CPSH N/A
- KZIA N/A
- EPS Growth
- CPSH N/A
- KZIA N/A
- EPS
- CPSH N/A
- KZIA N/A
- Revenue
- CPSH $21,937,262.00
- KZIA $1,655,324.00
- Revenue This Year
- CPSH N/A
- KZIA $806.89
- Revenue Next Year
- CPSH N/A
- KZIA N/A
- P/E Ratio
- CPSH N/A
- KZIA N/A
- Revenue Growth
- CPSH N/A
- KZIA 248000.00
- 52 Week Low
- CPSH $1.27
- KZIA $1.90
- 52 Week High
- CPSH $2.59
- KZIA $15.80
- Technical
- Relative Strength Index (RSI)
- CPSH 62.24
- KZIA 29.92
- Support Level
- CPSH $1.46
- KZIA $3.00
- Resistance Level
- CPSH $1.64
- KZIA $4.20
- Average True Range (ATR)
- CPSH 0.07
- KZIA 0.56
- MACD
- CPSH 0.01
- KZIA -0.15
- Stochastic Oscillator
- CPSH 77.38
- KZIA 5.82
About CPSH CPS Technologies Corp.
CPS Technologies Corp provides material solutions to the transportation, automotive, energy, computing/Internet, telecommunications, aerospace, defense, and oil and gas end markets. Its primary material solution is metal matrix composites (MMCs), which are a class of materials consisting of a combination of metal and ceramic. The company designs, manufactures and sells custom MMC components, which manages the performance and reliability of systems in the end markets. It also provides baseplates and housings used in radar, satellite and avionics applications. The company provides lids and heat spreaders used with integrated circuits in Internet switches and routers.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.